Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Gastroenterology. 2013 Aug;145(2):375-82.e1-2. doi: 10.1053/j.gastro.2013.04.005. Epub 2013 Apr 9.
BACKGROUND & AIMS: According to the National Center for Health Statistics (NCHS), chronic liver disease and cirrhosis is the 12(th) leading cause of death in the United States. However, this single descriptor might not adequately enumerate all deaths from liver disease. The aim of our study was to update data on liver mortality in the United States.
Mortality data were obtained from the Rochester Epidemiology Project (1999-2008) and the National Death Registry (1979-2008). Liver-specific mortality values were calculated. In contrast to the narrow NCHS definition, updated liver-related causes of death included other specific liver diagnoses (eg, hepatorenal syndrome), viral hepatitis, and hepatobiliary cancers.
The Rochester Epidemiology Project database contained information on 261 liver-related deaths, with an age- and sex-adjusted death rate of 27.0/100,000 persons (95% confidence interval: 23.7-30.3). Of these, only 71 deaths (27.2%) would have been captured by the NCHS definition. Of cases for which viral hepatitis or hepatobiliary cancer was the cause of death, 96.9% and 94.3% had liver-related immediate causes of death, respectively. In analysis of data from the National Death registry (2008), use of the updated definition increased liver mortality by >2-fold (from 11.7 to 25.7 deaths/100,000, respectively). Using NCHS definitions, liver-related deaths decreased from 18.9/100,000 in 1979 to 11.7/100,000 in 2008-a reduction of 38%. However, using the updated estimate, liver-related deaths were essentially unchanged from 1979 (25.8/100,000) to 2008 (25.7/100,000). Mortality burden was systematically underestimated among non-whites and persons of Hispanic ethnicity.
Based on analyses of the Rochester Epidemiology Project and National Death databases, liver-related mortality has been underestimated during the past 2 decades in the United States.
根据国家卫生统计中心(NCHS)的数据,慢性肝脏疾病和肝硬化是美国第 12 大死亡原因。然而,这一单一描述可能无法充分列举所有与肝脏疾病相关的死亡。本研究旨在更新美国肝脏死亡率的数据。
从罗切斯特流行病学项目(1999-2008 年)和国家死亡登记处(1979-2008 年)获得死亡率数据。计算特定于肝脏的死亡率值。与 NCHS 的狭义定义不同,更新后的与肝脏相关的死亡原因包括其他特定的肝脏诊断(如肝肾综合征)、病毒性肝炎和肝胆癌。
罗切斯特流行病学项目数据库包含了 261 例与肝脏相关的死亡信息,年龄和性别调整后的死亡率为 27.0/100,000 人(95%置信区间:23.7-30.3)。其中,只有 71 例(27.2%)符合 NCHS 的定义。在因病毒性肝炎或肝胆癌而死亡的病例中,分别有 96.9%和 94.3%的病例的直接死亡原因为肝脏疾病。在对国家死亡登记处(2008 年)的数据进行分析时,使用更新后的定义使肝脏死亡率增加了两倍以上(分别从 11.7 例/100,000 人增加到 25.7 例/100,000 人)。使用 NCHS 的定义,肝脏相关死亡从 1979 年的 18.9/100,000 人下降到 2008 年的 11.7/100,000 人,减少了 38%。然而,使用更新后的估计值,1979 年与 2008 年(25.8/100,000)的肝脏相关死亡基本保持不变。非白人和西班牙裔美国人的死亡率负担被系统地低估了。
根据罗切斯特流行病学项目和国家死亡数据库的分析,在过去的 20 年中,美国的肝脏相关死亡率被低估了。